What does Blood Cancer United's Therapy Acceleration Program (TAP) invest in?
Blood Cancer United's Therapy Acceleration Program (TAP) invests most often at Series C (100% of the rounds on record).
Blood Cancer United's Therapy Acceleration Program (TAP) highlights
- 01
1 cheques in the last 12 months
- 02
Mostly Series C: 100% of its rounds
What they do
- Type
- Growth equity (from a list, unverified)
- Cheque size
- Not stated
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first1 appearances
- 2026
1 round
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.